Blog Read the latest perspectives from our team of subject matter experts and others CEO Insights: Solving Healthcare’s Provider Data Challenge Through H1’s Acquisition of VedaToday, I’m proud to announce that H1 is acquiring Veda. This follows our acquisition of Ribbon Health in December 2024. By bringing in Veda’s suite of products, data, team, and… Continue reading → Read the article Post Topics:Artificial Intelligence Commercialization Drug Development Global Impact KOL Engagement Patient Representation Provider Data Post Industries:Digital Health Health Plans Pharmaceutical & Biotechnology Drug DevelopmentKOL EngagementThe Roles of KOLs in the Drug Development ProcessKey opinion leaders (KOLs) play an important role throughout the entire drug development and approval process. Most companies work with KOLs during Phases IIIa and IIIb as well as during… Continue reading → Read the article KOL EngagementOpinion Leader Identification: Big Data to KOL Short ListFor a pharmaceutical company, the decision to work with a certain key opinion leader (KOL) is very important. Engaging the right KOL is critical in establishing credibility among physicians… Continue reading → Read the article CommercializationThe Dos & Don’ts of Healthcare DatasetsWhere will you find your next MedTech sales opportunity? Healthcare datasets can be great tools for identifying prime prospects in your market. Leveraging healthcare datasets to market your MedTech systems,… Continue reading → Read the article CommercializationSales Associations; Networking Groups for MedTech ProfessionalsMedTech salespeople are understandably so focused on their day-to-day sales activities and quotas that they often miss opportunities to improve their knowledge, skills, and networking opportunities. The most proactive MedTech… Continue reading → Read the article KOL EngagementThe Science of Building and Maintaining a KOL DatabaseA lot has been written about KOLs and the value they can bring not only to drug development and commercialization in the pharmaceutical industry but also to companies developing medical… Continue reading → Read the article KOL EngagementThe Challenge of Performance Review for Medical Science LiaisonsThe daily responsibilities of a Medical Science Liaison (MSL) are varied and broad but a common denominator is their central role in interacting with, informing, and educating stakeholders in… Continue reading → Read the article«‹1617181920›
